Proven Osteoporosis Support

Ipriflavone (7-isopropoxy iso-flavone) is synthesized from the soy isoflavone daidzein, a plant estrogen. Studies have shown that ipriflavone prevents the breakdown of bone, improves uptake of bone minerals, relieves osteoporosis pain and increases mobility. Ipriflavone does not have any estrogenic effects on the female organs, however, and it can therefore be used for osteoporosis treatment and prevention even when hormone therapy is contraindicated.

In Japan and many European countries, ipriflavone is a registered treatment for osteoporosis. A dose of 600mg per day of ipriflavone was shown in one study to cause gains of up to 7.1% in bone mineral density.

Dose: 600mg per day, taken with a meal or as directed.

Click here to
Order This Concierge Product
WellevateThis is a separate website and you will need to create a new account to order.